Gas6/TAM Receptors in Systemic Lupus Erythematosus.

Dis Markers

Division of Immunology, Allergy and Rheumatology, Department of Internal Medicine, College of Medicine, University of Cincinnati, OH 45267, USA.

Published: January 2020

Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease associated with impaired immune system regulation. The exact mechanisms of SLE development remain to be elucidated. TAM receptor tyrosine kinases (RTKs) are important for apoptotic cell clearance, immune homeostasis, and resolution of immune responses. TAM deficiency leads to lupus-like autoimmune diseases. Activation of TAM receptors leads to proteolytic cleavage of the receptors, generating soluble forms of TAM. Circulating TAM receptors have an immunoregulatory function and may also serve as biomarkers for disease prognosis. Here, we review the biological function and signaling of TAM RTKs in the development and pathogenesis of lupus and lupus nephritis. Targeting Gas6/TAM pathways may be of therapeutic benefit. A discussion of potential TAM activation and inhibition in the treatment of lupus and lupus nephritis is included.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652053PMC
http://dx.doi.org/10.1155/2019/7838195DOI Listing

Publication Analysis

Top Keywords

systemic lupus
8
lupus erythematosus
8
tam receptors
8
lupus lupus
8
lupus nephritis
8
tam
7
lupus
6
gas6/tam receptors
4
receptors systemic
4
erythematosus systemic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!